Literature DB >> 299660

Cervical myelography with metrizamide by suboccipital puncture.

R E Gonsette1.   

Abstract

Cervical myelography with metrizamide (Amipaque) by suboccipital puncture was performed in 125 patients. Side effects were insignificant and there was no discomfort for the patient. The maximum amount to be injected is 3.75 g metrizamide (1.5 g iodine), and care must be taken in order to keep the contrast medium out of the basal cisterns. No premedication was used and no signs of irritation of the central nervous system were observed. With this technique the spinal cord and the nerve-roots are well demonstrated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 299660

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN: 0365-5954


  3 in total

1.  Adverse side effects of metrizamide in myelography.

Authors:  H J Gelmers
Journal:  Neuroradiology       Date:  1979-09-26       Impact factor: 2.804

2.  Cervical myelography with iohexol.

Authors:  P Nakstad; O Aaserud; A Helgetveit; R Nyberg-Hansen; T Ganes; T Bach-Gansmo
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

3.  Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double blind parallel study.

Authors:  P Nakstad; A Helgetveit; O Aaserud; T Ganes; R Nyberg-Hansen
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.